Cabergoline (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Cabergoline drug offered from Par Pharmaceutical, Inc.. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | Cabergoline |
SUBSTANCE NAME: | CABERGOLINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2005-12-29 |
END MARKETING DATE: | 0000-00-00 |
Cabergoline HUMAN PRESCRIPTION DRUG Details:
Item Description | Cabergoline from Par Pharmaceutical, Inc. |
LABELER NAME: | Par Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2005-12-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49884-673_1bef161f-47c6-445e-8006-dec4a68f5ed6 |
PRODUCT NDC: | 49884-673 |
APPLICATION NUMBER: | ANDA076310 |
Other CABERGOLINE Pharmaceutical Manufacturers / Labelers: